首页> 美国卫生研究院文献>Bentham Open Access >Pharmacological Characteristics and Clinical Applications of K201
【2h】

Pharmacological Characteristics and Clinical Applications of K201

机译:K201的药理特性及临床应用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

K201 is a 1,4-benzothiazepine derivative that is a promising new drug with a strong cardioprotective effect. We initially discovered K201 as an effective suppressant of sudden cardiac cell death due to calcium overload. K201 is a nonspecific blocker of sodium, potassium and calcium channels, and its cardioprotective effect is more marked than those of nicorandil, prazosine, propranolol, verapamil and diltiazem. Recently, K201 has also been shown to have activities indicated for treatment of atrial fibrillation, ventricular fibrillation, heart failure and ischemic heart disease, including action as a multiple-channel blocker, inhibition of diastolic Ca2+ release from the sarcoplasmic reticulum, suppression of spontaneous Ca2+ sparks and Ca2+ waves, blockage of annexin V and provision of myocardial protection, and improvement of norepinephrine-induced diastolic dysfunction. Here, we describe the pharmacological characteristics and clinical applications of K201.
机译:K201是1,4-苯并硫氮杂ze衍生物,是一种有前途的新药,具有强大的心脏保护作用。最初,我们发现K201可有效抑制由于钙超载导致的心脏猝死。 K201是钠,钾和钙通道的非特异性阻滞剂,其心脏保护作用比尼可地尔,吡唑嗪,普萘洛尔,维拉帕米和地尔硫卓的心脏保护作用更为显着。最近,K201还被证明具有治疗房颤,心室纤颤,心力衰竭和缺血性心脏病的活性,包括作为多通道阻滞剂,抑制舒张性Ca 2 + 释放质网,自发Ca 2 + 火花和Ca 2 + 波的抑制,膜联蛋白V的阻滞和心肌保护的提供,以及去甲肾上腺素引起的舒张功能障碍的改善。在这里,我们描述了K201的药理特性和临床应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号